(S)-1-(5-chloro-2-((3,5-difluorophenyl)amino)pyrimidin-4-yl)-N-(4-morpholino-3-(piperidine-1-carbonyl)phenyl)pyrrolidine-2-carboxamide

ID: ALA4849644

PubChem CID: 164610542

Max Phase: Preclinical

Molecular Formula: C31H34ClF2N7O3

Molecular Weight: 626.11

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(N2CCOCC2)c(C(=O)N2CCCCC2)c1)[C@@H]1CCCN1c1nc(Nc2cc(F)cc(F)c2)ncc1Cl

Standard InChI:  InChI=1S/C31H34ClF2N7O3/c32-25-19-35-31(37-23-16-20(33)15-21(34)17-23)38-28(25)41-10-4-5-27(41)29(42)36-22-6-7-26(39-11-13-44-14-12-39)24(18-22)30(43)40-8-2-1-3-9-40/h6-7,15-19,27H,1-5,8-14H2,(H,36,42)(H,35,37,38)/t27-/m0/s1

Standard InChI Key:  GRXZMOXSVVBOIU-MHZLTWQESA-N

Molfile:  

 
     RDKit          2D

 44 49  0  0  0  0  0  0  0  0999 V2000
    7.5867   -5.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3898   -5.9546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2488   -4.6355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5850   -4.7018    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1403   -3.3494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9427   -3.7395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4978   -4.9699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8120   -4.9740    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.3599   -3.7448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9731   -4.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3663   -4.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1877   -3.0264    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.9455   -4.5657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6356   -4.9258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8086   -4.1227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2449   -5.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7974   -5.2438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1988   -3.5760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8046   -3.2817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2316   -3.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7872   -4.5623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5227   -4.5662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2292   -2.5095    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6566   -4.9729    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0738   -4.9711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7863   -3.7407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5836   -3.8694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2334   -4.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1941   -4.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0259   -5.2202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4188   -3.8324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5239   -3.7431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0662   -3.3295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6354   -5.7613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4662   -6.5617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0714   -7.1055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8493   -6.8541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0186   -6.0537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4098   -5.5046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9242   -3.0953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0926   -2.2955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4827   -1.7454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7015   -2.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5302   -2.8065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 24 11  1  0
 22 28  1  0
 16 30  2  0
 14 16  1  0
 29 27  2  0
 26 12  1  0
 27 15  1  0
 13 24  1  0
 30 29  1  0
 10  4  2  0
 20 32  1  0
 20 23  1  0
 25 21  1  0
 22  8  1  0
 28 13  2  0
 10  5  1  0
 31 18  1  0
 26 33  1  0
 21 26  2  0
  3 31  1  6
  3  7  1  0
 11 25  2  0
 31 19  2  0
  6 20  2  0
 32 22  2  0
 17  3  1  0
  1  2  1  0
 21  7  1  0
 13  6  1  0
  7  1  1  0
  2 17  1  0
 18 15  1  0
  9 11  1  0
 29 10  1  0
 15 14  2  0
 33  9  2  0
 34 35  1  0
 34 39  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 30 34  1  0
  5 40  1  0
  5 44  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4849644

    ---

Associated Targets(Human)

KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 626.11Molecular Weight (Monoisotopic): 625.2380AlogP: 5.22#Rotatable Bonds: 7
Polar Surface Area: 102.93Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.06CX Basic pKa: 2.97CX LogP: 5.33CX LogD: 5.33
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.37Np Likeness Score: -1.82

References

1. Li T, Li C, Yang J, Guo M, Cao Z, Wang X, Jiang N, Zhai X..  (2021)  Discovery of novel 2-phenylamino-4-prolylpyrimidine derivatives as TRK/ALK dual inhibitors with promising antitumor effects.,  47  [PMID:34534734] [10.1016/j.bmc.2021.116396]

Source